The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found.
The study authors said the research is among the first to explore how the enormous nationwide spike in the use of weight loss drugs correlated with the number of patients choosing to undergo stomach operations to lose weight.
Using a database of health insurance claims from more than 17 million adults, Mass General Brigham researchers identified people diagnosed with obesity but not diabetes…